Glycerol phenylbutyrate is employed to decrease ammonia levels in patients with ARG1 deficiencies by bypassing ARG1's role in the urea cycle, which helps mitigate the hyperammonemia typically associated with these deficiencies. The altered expression of ARG1 in tumors also suggests potential indirect targeting by immunotherapy drugs in cancer treatment, although specifics are not provided.